Benzinga | May 4, 2021 05:11PM EDT

Deciphera Pharmaceuticals Q1 EPS $(1.06) Beats $(1.07) Estimate, Sales $25.16M Beat $22.41M Estimate

Deciphera Pharmaceuticals (NASDAQ:DCPH) reported quarterly losses of $(1.06) per share which beat the analyst consensus estimate of $(1.07) by 0.93 percent. This is a 22.06 percent increase over losses of $(1.36) per share from the same period last year. The company reported quarterly sales of $25.16 million which beat the analyst consensus estimate of $22.41 million by 12.25 percent. This is a 40.47K percent increase over sales of $62.00 thousand the same period last year.